Publication

Article

Internal Medicine World Report

July 2014
Volume

High Carbohydrate Intake Linked to Increased Insulin Requirements

Since many patients have insulin resistance, prescribing insulin therapy for diabetes often requires trial and error.

Since many patients have insulin resistance, prescribing insulin therapy for diabetes often requires trial and error.

Although there is a non-linear relationship between insulin requirements and visible parameters such as body size, research published in an upcoming issue of Diabetes & Metabolic Syndrome: Clinical Research & Reviews suggests a particular clinical profile associated with insulin resistance can identify those in need of higher insulin doses.

For their observational study, researchers from a large tertiary care center in India examined total daily insulin requirements (TDIR) and carbohydrate consumption among 60 patients aged between 30-75 years who had been diagnosed with type 2 diabetes mellitus (T2DM) for an average of 10 years. At the start of the study, all patients had received a stable insulin dose for at least 6 months, as well as achieved an acceptable level of glycated hemoglobin (HbA1c) between 6-7.5%.

The researchers stratified the participants into 3 groups:

  • Group 1: TDIR <1 U/kg
  • Group 2: TDIR 1—2 U/kg
  • Group 3: TDIR >2 U/kg

According to the study authors, patients in Group 3 were most likely to have insulin resistance, as they had a pronounced tendency toward lower body weight and body mass index (BMI) compared to the other 2 groups. Additionally, participants in Group 3 exceeded the recommended daily carbohydrate intake of 130 g. Nevertheless, all 3 groups had similar incidence rates of hypoglycemic episodes and complications.

Since the researchers concluded that low body weight and high carbohydrate intake increase insulin requirements, they advised clinicians to monitor carbohydrate intake among T2DM patients, especially those with BMI <21 who require insulin doses that exceed 2 U/kg.

Related Videos
Diabetes Dialogue: Exploring New Horizons in Incretin Therapy for Diabetes and Weight Loss | Image Credit: HCPLive
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.